Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-08-07
1986-11-18
Trousof, Natalie
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540228, 540314, 540329, 514202, 514209, A61K 3143, A61K 31545, C07D49976, C07D50114
Patent
active
046236449
ABSTRACT:
This invention relates to the hybridization of streptolydigin, tirandamycin and sorbic acid to penicillin and cephalosporin nuclei.
REFERENCES:
Reusser, F., "Tirandamycin, An Inhibitor of Bacterial Ribonucleic Acid Polymerase", Antimicrobial Agents and Chemotherapy, 10 (No. 4): 618-622, (1976).
Reusser Fritz
Rinehart, Jr. Kenneth L.
Clarke Vera C.
The Upjohn Company
Trousof Natalie
Weber Kenneth A.
LandOfFree
Acylation of tirandamycic, streptolic and sorbic acids to cephal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylation of tirandamycic, streptolic and sorbic acids to cephal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylation of tirandamycic, streptolic and sorbic acids to cephal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1617838